BOOK
Primary Care Dermatology, An Issue of Primary Care: Clinics in Office Practice, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of Primary Care: Clinics in Office Practice, Guest Edited by George G.A. Pujalte, MD, is devoted to Primary Care Dermatology. Dr. Pujalte has assembled a group of expert authors to review the following topics: Urticaria and allergy-mediated conditions; Dermatologic manifestations of systemic diseases; Viral skin infections; Fungal skin infections; Bacterial skin infections; Parasitic skin infections; Pressure and friction injuries to the skin; Sunburn, thermal, and chemical injuries to the skin; Acne; Alopecia; Nail deformities and injuries; and Skin cancer.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Primary Care Dermatology\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITOR | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Foreword: Pattern Recognition\r | vii | ||
| Preface: Beyond Superficial: Primary Care Dermatology\r | vii | ||
| Evaluation and Management of Acne\r | vii | ||
| Urticaria and Allergy-Mediated Conditions\r | vii | ||
| Bacterial Skin Infections\r | vii | ||
| Superficial Fungal Infections\r | vii | ||
| Viral Skin Diseases\r | viii | ||
| Evaluation and Management of the Hair Loss Patient in the Primary Care Setting\r | viii | ||
| Sunburn, Thermal, and Chemical Injuries to the Skin\r | viii | ||
| Dermatologic Manifestations of Systemic Diseases\r | ix | ||
| Pressure and Friction Injuries in Primary Care\r | ix | ||
| Skin Cancer\r | ix | ||
| Parasitic Skin Infections for Primary Care Physicians\r | ix | ||
| Nail Deformities and Injuries\r | ix | ||
| PRIMARY CARE:\rCLINICS IN OFFICE PRACTICE\r | xi | ||
| FORTHCOMING ISSUES | xi | ||
| March 2016 | xi | ||
| June 2016 | xi | ||
| September 2016 | xi | ||
| RECENT ISSUES | xi | ||
| September 2015 | xi | ||
| June 2015 | xi | ||
| March 2015 | xi | ||
| Foreword: Pattern Recognition \r | xiii | ||
| REFERENCES | xiv | ||
| Preface: Beyond Superficial: Primary Care Dermatology \r | xv | ||
| Evaluation and Management of Acne | 465 | ||
| Key points | 465 | ||
| INTRODUCTION | 465 | ||
| EPIDEMIOLOGY | 465 | ||
| PATHOPHYSIOLOGY | 466 | ||
| DIAGNOSIS | 466 | ||
| TREATMENT | 468 | ||
| MANAGEMENT OF ACNE | 468 | ||
| TOPICAL RETINOIDS | 468 | ||
| TOPICAL ANTIMICROBIALS | 469 | ||
| ORAL ANTIBIOTICS | 469 | ||
| HORMONAL THERAPY AND ORAL CONTRACEPTIVES | 470 | ||
| ORAL RETINOIDS | 470 | ||
| TREATMENT OF ACNE MECHANICA (SPORTS-INDUCED ACNE) | 470 | ||
| SUMMARY | 470 | ||
| REFERENCES | 470 | ||
| Urticaria and Allergy-Mediated Conditions | 473 | ||
| Key points | 473 | ||
| DESCRIPTION | 473 | ||
| EPIDEMIOLOGY | 475 | ||
| Incidence | 475 | ||
| Prevalence | 475 | ||
| DIAGNOSIS | 475 | ||
| Causes | 476 | ||
| Treatment | 477 | ||
| ANGIOEDEMA | 478 | ||
| Description | 478 | ||
| Epidemiology | 478 | ||
| Pathogenesis and Causes | 478 | ||
| Diagnosis | 478 | ||
| Treatment | 478 | ||
| DERMATITIS | 479 | ||
| Description | 479 | ||
| Epidemiology | 479 | ||
| Diagnosis | 479 | ||
| Causes | 480 | ||
| Treatment | 480 | ||
| ECZEMA/ATOPIC DERMATITIS | 481 | ||
| Description | 481 | ||
| Epidemiology | 481 | ||
| Diagnosis | 481 | ||
| Treatment | 481 | ||
| REFERENCES | 483 | ||
| Bacterial Skin Infections | 485 | ||
| Key points | 485 | ||
| INTRODUCTION | 485 | ||
| IMPETIGO | 486 | ||
| Evaluation and Work-Up | 486 | ||
| Management Strategies | 487 | ||
| Pharmacologic Strategies | 487 | ||
| Follow-Up Care | 488 | ||
| ERYSIPELAS | 488 | ||
| Management Strategies | 489 | ||
| Pharmacologic Strategies | 489 | ||
| Follow-Up Care | 489 | ||
| CELLULITIS | 490 | ||
| Microbiology | 490 | ||
| Methicillin-Resistant Staphylococcus aureus Versus Methicillin-Sensitive Staphylococcus aureus | 490 | ||
| Evaluation/Work-Up | 491 | ||
| Patient history | 491 | ||
| Physical examination | 492 | ||
| Imaging and additional testing | 492 | ||
| Management Strategies | 493 | ||
| Treatment Strategies | 493 | ||
| Pharmacologic Strategies: Nonpurulent | 493 | ||
| Pharamacolic Strateges: Purulent | 495 | ||
| Nonpharmacologic Strategies | 495 | ||
| Self-Management Strategies | 496 | ||
| Evaluation, Adjustment, Recurrence | 496 | ||
| ABSCESSES | 496 | ||
| Evaluation/Work-Up | 496 | ||
| Patient history | 496 | ||
| Physical examination | 496 | ||
| Imaging and additional testing | 497 | ||
| Management Strategies | 497 | ||
| Pharmacologic Strategies | 497 | ||
| Nonpharmacologic Strategies | 497 | ||
| Self-Management Strategies | 497 | ||
| Evaluation, Adjustment, Recurrence | 497 | ||
| SUMMARY | 498 | ||
| REFERENCES | 498 | ||
| Superficial Fungal Infections | 501 | ||
| Key points | 501 | ||
| INTRODUCTION | 501 | ||
| Transmission | 502 | ||
| Classification | 502 | ||
| Diagnosis | 502 | ||
| TINEA PEDIS | 502 | ||
| Pitted Keratolysis | 504 | ||
| TINEA CRURIS | 504 | ||
| TINEA CORPORIS | 505 | ||
| Deep Inflammatory Lesions | 505 | ||
| TINEA OF THE HAND | 506 | ||
| Tinea Incognito | 507 | ||
| TINEA OF THE SCALP | 507 | ||
| Trichophyton tonsurans | 508 | ||
| TINEA OF THE BEARD | 509 | ||
| TINEA VERSICOLOR | 510 | ||
| CANDIDIASIS | 511 | ||
| Oropharyngeal Candidiasis | 512 | ||
| Genital Candidiasis | 513 | ||
| Candida Balanitis | 513 | ||
| SUMMARY | 514 | ||
| REFERENCES | 514 | ||
| Viral Skin Diseases | 517 | ||
| Key points | 517 | ||
| MEASLES (RUBEOLA) | 517 | ||
| MANAGEMENT STRATEGIES | 518 | ||
| Management Goals | 518 | ||
| Treatment Strategies | 518 | ||
| Nonpharmacologic strategies | 518 | ||
| Pharmacologic strategies | 518 | ||
| Self-Management Strategies | 518 | ||
| Evaluation, Adjustment, Recurrence | 518 | ||
| Complications | 518 | ||
| Recurrence | 518 | ||
| EVALUATION/WORKUP | 518 | ||
| Patient History | 518 | ||
| Physical Examination | 519 | ||
| Imaging and Additional Testing | 520 | ||
| RUBELLA (GERMAN MEASLES) | 520 | ||
| MANAGEMENT STRATEGIES | 520 | ||
| Management Goals | 520 | ||
| Treatment Strategies | 521 | ||
| Evaluation, Adjustment, Recurrence | 521 | ||
| Complications | 521 | ||
| Recurrence | 521 | ||
| Prevention | 521 | ||
| EVALUATION/WORKUP | 521 | ||
| Patient History | 521 | ||
| Physical Examination | 521 | ||
| Imaging and Additional Testing | 522 | ||
| ERYTHEMA INFECTIOSUM (FIFTH DISEASE) | 523 | ||
| MANAGEMENT STRATEGIES | 523 | ||
| Management Goals | 523 | ||
| Treatment Strategies | 523 | ||
| Evaluation, Adjustment, Recurrence | 524 | ||
| Complications | 524 | ||
| Recurrence | 524 | ||
| EVALUATION/WORKUP | 524 | ||
| Patient History | 524 | ||
| Physical Examination | 524 | ||
| Imaging and Additional Testing | 524 | ||
| ROSEOLA INFANTUM (SIXTH DISEASE OR ERYTHEMA SUBITUM) | 526 | ||
| MANAGEMENT STRATEGIES | 526 | ||
| Management Goals | 526 | ||
| Treatment Strategies | 526 | ||
| Evaluation, Adjustment, Recurrence | 526 | ||
| Complications | 526 | ||
| Recurrence | 526 | ||
| EVALUATION AND WORKUP | 526 | ||
| Patient History | 526 | ||
| Physical Examination | 526 | ||
| Imaging and Additional Testing | 528 | ||
| HERPES SIMPLEX | 528 | ||
| MANAGEMENT STRATEGIES | 529 | ||
| Management Goals | 529 | ||
| Treatment Strategies | 529 | ||
| Evaluation, Adjustment, Recurrence | 529 | ||
| Complications | 529 | ||
| Recurrence | 530 | ||
| EVALUATION/WORKUP | 531 | ||
| Imaging and Additional Testing | 533 | ||
| VARICELLA (CHICKENPOX) | 534 | ||
| MANAGEMENT STRATEGIES | 534 | ||
| Management Goals | 534 | ||
| Treatment Strategies | 534 | ||
| Evaluation, Adjustment, Recurrence | 535 | ||
| Complications | 535 | ||
| Recurrence | 535 | ||
| Prevention | 535 | ||
| EVALUATION/WORKUP | 535 | ||
| Patient History | 535 | ||
| Physical Examination | 535 | ||
| Imaging and Additional Testing | 536 | ||
| HERPES ZOSTER (SHINGLES) | 536 | ||
| MANAGEMENT STRATEGIES | 536 | ||
| Management Goals | 536 | ||
| Treatment Strategies | 537 | ||
| Nonpharmacologic treatment | 537 | ||
| Pharmacologic treatment | 537 | ||
| Self-Management Strategies | 537 | ||
| Evaluation, Adjustment, Recurrence | 537 | ||
| Recurrence | 537 | ||
| EVALUATION/WORKUP | 537 | ||
| Patient History | 537 | ||
| Physical Examination | 539 | ||
| Imaging and Additional Testing | 540 | ||
| KAPOSI SARCOMA–ASSOCIATED HERPESVIRUS | 540 | ||
| MANAGEMENT STRATEGIES | 541 | ||
| Management Goals | 541 | ||
| Treatment Strategies | 542 | ||
| Evaluation, Adjustment, Recurrence | 542 | ||
| Evaluation for other HHV-8-associated diseases | 542 | ||
| Complications associated with human herpesvirus-8 and Kaposi sarcoma treatment | 542 | ||
| Evaluation/Workup | 543 | ||
| Imaging and Additional Testing | 544 | ||
| WARTS (VERRUCA) | 545 | ||
| MANAGEMENT STRATEGIES | 545 | ||
| Management Goals | 545 | ||
| Treatment Strategies | 545 | ||
| Self-Management Strategies | 545 | ||
| Evaluation, Adjustment, Recurrence | 545 | ||
| Complications | 545 | ||
| Recurrence | 546 | ||
| Prevention | 547 | ||
| EVALUATION AND WORKUP | 548 | ||
| Patient History and Physical Examination | 548 | ||
| Imaging and Additional Testing | 549 | ||
| HAND, FOOT, AND MOUTH DISEASE | 549 | ||
| MANAGEMENT STRATEGIES | 550 | ||
| Management Goals | 550 | ||
| Treatment Strategies | 550 | ||
| Evaluation, Adjustment, Recurrence | 550 | ||
| Complications | 550 | ||
| Recurrence | 550 | ||
| EVALUATION/WORKUP | 550 | ||
| Patient History | 550 | ||
| Physical Examination | 551 | ||
| Imaging and Additional Testing | 551 | ||
| MOLLUSCUM CONTAGIOSUM | 552 | ||
| MANAGEMENT STRATEGIES | 552 | ||
| Management Goals | 552 | ||
| Treatment Strategies | 552 | ||
| Evaluation, Adjustment, Recurrence | 552 | ||
| Complications | 552 | ||
| Recurrence | 552 | ||
| EVALUATION AND WORKUP | 552 | ||
| Patient History | 552 | ||
| Physical Examination | 553 | ||
| Imaging and Additional Testing | 555 | ||
| GIANOTTI-CROSTI SYNDROME | 555 | ||
| MANAGEMENT STRATEGIES | 555 | ||
| Management Goals | 555 | ||
| Treatment Strategies | 555 | ||
| Evaluation, Adjustment, Recurrence | 556 | ||
| EVALUATION AND WORKUP | 556 | ||
| Patient History | 556 | ||
| Physical Examination | 556 | ||
| Imaging and Additional Testing | 556 | ||
| ORF (CONTAGIOUS ECTHYMA) | 557 | ||
| MANAGEMENT STRATEGIES | 558 | ||
| Management Goals | 558 | ||
| Treatment Strategies | 558 | ||
| Evaluation, Adjustment, Recurrence | 558 | ||
| Complication | 558 | ||
| Recurrence | 558 | ||
| EVALUATION/WORKUP | 558 | ||
| Patient History | 558 | ||
| Physical Examination | 558 | ||
| Imaging and Additional Testing | 559 | ||
| MONKEYPOX | 559 | ||
| MANAGEMENT STRATEGIES | 559 | ||
| Management Goals | 559 | ||
| Treatment Strategies | 559 | ||
| Nonpharmacologic strategies | 559 | ||
| Pharmacologic strategies | 559 | ||
| Self-Management Strategies | 559 | ||
| Evaluation, Adjustment, Recurrence | 560 | ||
| Complications | 560 | ||
| EVALUATION AND WORKUP | 560 | ||
| Patient History | 560 | ||
| Physical Examination | 560 | ||
| Imaging and Additional Testing | 560 | ||
| SMALLPOX | 560 | ||
| MANAGEMENT STRATEGIES | 561 | ||
| Management Goals | 561 | ||
| Treatment Strategies | 561 | ||
| Evaluation, Adjustment, Recurrence | 561 | ||
| EVALUATION AND WORKUP | 561 | ||
| Patient History | 561 | ||
| Physical Examination | 561 | ||
| OTHER VIRAL ILLNESS WITH CUTANEOUS MANIFESTATIONS | 561 | ||
| Herpangina | 561 | ||
| Infectious Mononucleosis | 562 | ||
| Ebola | 563 | ||
| Chikungunya Fever | 563 | ||
| Dengue Fever | 563 | ||
| Viral Hemorrhagic Fever | 564 | ||
| Vaccination | 564 | ||
| SUMMARY | 566 | ||
| REFERENCES | 566 | ||
| Evaluation and Management of the Hair Loss Patient in the Primary Care Setting | 569 | ||
| Key points | 569 | ||
| INTRODUCTION | 569 | ||
| CLASSIFICATION OF ALOPECIAS | 570 | ||
| Noncicatricial Alopecias | 570 | ||
| Androgenetic/pattern alopecia | 570 | ||
| Alopecia areata | 572 | ||
| Telogen effluvium | 573 | ||
| Tinea capitis | 574 | ||
| Traction alopecia | 576 | ||
| Trichotillomania | 577 | ||
| Cicatricial Alopecias | 579 | ||
| APPROACH TO THE PATIENT WITH ALOPECIA | 581 | ||
| Diagnosis | 581 | ||
| Clinical history | 581 | ||
| Physical examination | 583 | ||
| The scalp biopsy | 583 | ||
| Management | 584 | ||
| Laboratory work-up | 584 | ||
| Treatment | 584 | ||
| When to refer to a dermatologist | 586 | ||
| SUMMARY | 586 | ||
| REFERENCES | 587 | ||
| Sunburn, Thermal, and Chemical Injuries to the Skin | 591 | ||
| Key points | 591 | ||
| BODY SURFACE AREA | 592 | ||
| THERMAL BURNS | 592 | ||
| Frostbite | 594 | ||
| Chemical Burns | 595 | ||
| SUNBURN | 596 | ||
| Background | 596 | ||
| Cancer Risk | 598 | ||
| Melanoma | 598 | ||
| Nonmelanoma skin cancer | 598 | ||
| Eye Injury | 598 | ||
| Prevention | 598 | ||
| Sunscreen | 598 | ||
| Clothing | 599 | ||
| Management of Burns | 599 | ||
| ACUTE MANAGEMENT | 600 | ||
| SPECIAL CONSIDERATION FOR SPECIFIC BURN SITES | 600 | ||
| Facial Burns | 600 | ||
| Ocular Burns | 600 | ||
| Chemical Burns of the Face and Eye | 601 | ||
| Hand Burns | 601 | ||
| Immersion Burns | 601 | ||
| TREATMENT OF BURNS | 601 | ||
| Fluid Resuscitation | 601 | ||
| COMPARTMENT SYNDROME AND CIRCUMFERENTIAL BURNS | 602 | ||
| TOPICAL AND SYSTEMIC TREATMENTS | 602 | ||
| OUTCOMES OF BURN INJURY | 602 | ||
| SUMMARY | 603 | ||
| REFERENCES | 603 | ||
| Dermatologic Manifestations of Systemic Diseases | 607 | ||
| Key points | 607 | ||
| PYODERMA GANGRENOSUM | 607 | ||
| Definition | 607 | ||
| Epidemiology | 608 | ||
| Clinical Presentation | 608 | ||
| Differential Diagnosis | 608 | ||
| Associated Gastrointestinal Conditions | 608 | ||
| Diagnosis | 609 | ||
| Treatment | 609 | ||
| Prognosis | 609 | ||
| ERYTHEMA NODOSUM | 609 | ||
| Definition | 609 | ||
| Epidemiology | 609 | ||
| Clinical Presentation | 609 | ||
| Lesions of erythema nodosum | 609 | ||
| Differential Diagnosis | 610 | ||
| Associated Gastrointestinal Conditions | 610 | ||
| Diagnosis | 610 | ||
| Laboratory evaluation | 610 | ||
| Evaluation of inflammatory bowel disease | 610 | ||
| Deep incisional or excisional skin biopsy | 610 | ||
| Treatment | 611 | ||
| Prognosis | 611 | ||
| APTHOUS STOMATITIS | 611 | ||
| Definition | 611 | ||
| Epidemiology | 611 | ||
| Clinical Presentation | 611 | ||
| Differential Diagnosis | 612 | ||
| Associated Gastrointestinal Conditions | 612 | ||
| Diagnosis | 612 | ||
| Treatment | 612 | ||
| Prognosis | 612 | ||
| DERMATITIS HERPETIFORMIS | 613 | ||
| Definition | 613 | ||
| Epidemiology | 613 | ||
| Clinical Presentation | 613 | ||
| Differential Diagnosis | 613 | ||
| Associated Gastrointestinal Condition | 613 | ||
| Diagnosis | 613 | ||
| Treatment | 614 | ||
| Prognosis | 614 | ||
| LICHEN PLANUS | 614 | ||
| Definition | 614 | ||
| Epidemiology | 614 | ||
| Clinical Features | 614 | ||
| Differential Diagnosis | 614 | ||
| Associated Gastrointestinal Condition | 615 | ||
| Diagnosis | 615 | ||
| Treatment | 616 | ||
| Cutaneous lichen planus | 616 | ||
| Oral lichen planus | 616 | ||
| Other treatment modalities | 616 | ||
| Prognosis | 616 | ||
| ACUTE CUTANEOUS LUPUS FROM SYSTEMIC LUPUS ERYTHEMATOSUS | 616 | ||
| Definition | 616 | ||
| Epidemiology | 617 | ||
| Clinical Presentation | 617 | ||
| Differential Diagnosis | 617 | ||
| Diagnosis | 617 | ||
| Treatment | 618 | ||
| Prognosis | 618 | ||
| DISCOID LUPUS ERYTHEMATOUS | 619 | ||
| Definition | 619 | ||
| Epidemiology | 619 | ||
| Clinical Presentation | 619 | ||
| Differential Diagnosis | 620 | ||
| Diagnosis | 620 | ||
| Treatment | 620 | ||
| Prognosis | 620 | ||
| HELIOTROPE RASH AND GOTTRON PAPULES OF DERMATOMYOSITIS | 620 | ||
| Definition | 620 | ||
| Epidemiology | 620 | ||
| Clinical Presentation | 621 | ||
| Differential Diagnosis | 621 | ||
| Diagnosis | 622 | ||
| Treatment | 622 | ||
| Prognosis | 623 | ||
| SKIN SCLEROSIS AND RAYNAUD PHENOMENON OF SCLERODERMA | 623 | ||
| Definition | 623 | ||
| Epidemiology | 623 | ||
| Clinical Presentation | 623 | ||
| CREST SYNDROME | 624 | ||
| Differential Diagnosis | 625 | ||
| Diagnosis | 626 | ||
| Treatment | 626 | ||
| Prognosis | 626 | ||
| MORPHEA | 627 | ||
| Definition | 627 | ||
| Epidemiology | 627 | ||
| Clinical Presentation | 627 | ||
| Differential Diagnosis | 627 | ||
| Diagnosis | 627 | ||
| Treatment/Prognosis | 628 | ||
| SUMMARY | 628 | ||
| REFERENCES | 628 | ||
| Pressure and Friction Injuries in Primary Care | 631 | ||
| Key points | 631 | ||
| INTRODUCTION | 631 | ||
| PRESSURE INJURY | 632 | ||
| Pressure Ulcer | 632 | ||
| History | 632 | ||
| Examination | 632 | ||
| Treatment | 635 | ||
| Prevention | 636 | ||
| Special population: athletes | 636 | ||
| Talon Noir | 637 | ||
| Skin Cancer | 645 | ||
| Key points | 645 | ||
| INTRODUCTION | 645 | ||
| SKIN BIOPSY | 646 | ||
| Indication to Biopsy | 646 | ||
| Contraindications to Biopsy | 646 | ||
| Site Selection | 646 | ||
| Types of Skin Biopsy | 646 | ||
| Punch Biopsy | 646 | ||
| Shave Biopsy | 647 | ||
| Excisional Biopsy | 647 | ||
| BASAL CELL CARCINOMA | 647 | ||
| Epidemiology | 648 | ||
| Risk Factors | 648 | ||
| Clinical Presentation | 648 | ||
| Nodular Basal Cell Carcinoma | 648 | ||
| Superficial Basal Cell Carcinoma | 648 | ||
| Morpheaform Basal Cell Carcinoma | 649 | ||
| Treatment | 649 | ||
| SQUAMOUS CELL CARCINOMA | 650 | ||
| Epidemiology | 650 | ||
| Bowen Disease | 650 | ||
| Erythroplasia of Queyrat | 650 | ||
| Risk Factors | 650 | ||
| Clinical Presentation | 650 | ||
| Diagnosis | 650 | ||
| Treatment | 651 | ||
| Risk Factors for Recurrence of Cutaneous Squamous Cell Carcinoma | 651 | ||
| MELANOMA | 651 | ||
| Epidemiology | 652 | ||
| Superficial Melanoma | 652 | ||
| Nodular Melanoma | 652 | ||
| Lentigo Maligna Melanoma | 652 | ||
| Acral Lentiginous | 653 | ||
| Melanonychia Differential | 653 | ||
| Risk Factors | 654 | ||
| Clinical Presentation | 654 | ||
| Diagnosis | 657 | ||
| Treatment | 657 | ||
| Monitoring | 658 | ||
| Skin Cancer Prevention | 658 | ||
| REFERENCES | 658 | ||
| Parasitic Skin Infections for Primary Care Physicians | 661 | ||
| Key points | 661 | ||
| INTRODUCTION | 661 | ||
| SCABIES | 662 | ||
| General Information and Cause | 662 | ||
| Pathophysiology | 662 | ||
| Risk Factors | 662 | ||
| Transmission | 663 | ||
| Presentation | 663 | ||
| Diagnosis | 664 | ||
| Treatment | 664 | ||
| Complications | 664 | ||
| Prevention | 664 | ||
| PEDICULOSIS | 664 | ||
| General Information | 664 | ||
| PEDICULOSIS CAPITIS | 665 | ||
| Cause and Risk Factors | 665 | ||
| Epidemiology | 665 | ||
| Transmission | 666 | ||
| Presentation | 666 | ||
| Diagnosis | 666 | ||
| Treatment | 667 | ||
| Complications | 667 | ||
| Prevention | 667 | ||
| PEDICULOSIS PUBIS | 667 | ||
| Cause | 667 | ||
| Transmission | 670 | ||
| Epidemiology | 670 | ||
| Presentation | 670 | ||
| Diagnosis | 671 | ||
| Treatment | 671 | ||
| Complications | 672 | ||
| Prevention | 672 | ||
| PEDICULOSIS CORPORIS | 672 | ||
| Cause | 672 | ||
| Epidemiology and Risk Factors | 673 | ||
| Transmission | 673 | ||
| Presentation | 673 | ||
| Diagnosis | 673 | ||
| Treatment | 673 | ||
| Complications | 674 | ||
| Prevention | 674 | ||
| SUMMARY/DISCUSSION | 674 | ||
| REFERENCES | 674 | ||
| Nail Deformities and Injuries | 677 | ||
| Key points | 677 | ||
| NAIL ANATOMY | 677 | ||
| NAIL ABNORMALITIES | 678 | ||
| Onychomycosis | 678 | ||
| Leukonychia | 679 | ||
| Mees lines | 680 | ||
| Terry nails | 680 | ||
| Lindsay nail | 680 | ||
| Muehrcke lines | 680 | ||
| Melanonychia, Longitudinal | 680 | ||
| Nail Pitting | 680 | ||
| Subungual Hematoma | 681 | ||
| Beau Lines | 682 | ||
| Onycholysis | 682 | ||
| Pterygium Unguis | 683 | ||
| Longitudinal Ridging (Onychorrhexis) | 683 | ||
| Trachyonychia | 684 | ||
| Clubbing | 684 | ||
| Paronychia | 686 | ||
| Ingrown Toenails | 687 | ||
| Nail Avulsion Procedure | 689 | ||
| SUMMARY | 691 | ||
| REFERENCES | 691 |